Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 18, 2019
Tumor grade may be used to select patients with multifocal hepatocellular carcinoma for resectionSamantha M Ruff, Luke D Rothermel, Laurence P Diggs, et al.
Journal of Neurointerventional Surgery|June 25, 2013
Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?Grant C Sorkin, Travis M Dumont, Michael M Wach, et al.
Journal of Surgical Oncology|May 3, 2019
Postbiliary drainage rates of cholangitis are impacted by procedural technique for patients with supra-ampullary cholangiocarcinoma: A SEER-Medicare analysisChristine M Kariya, Michael M Wach, Samantha M Ruff, et al.
The Annals of Thoracic Surgery|December 30, 2020
Characteristics of Matriculants to Thoracic Surgery Residency Training ProgramsJustin A Drake, Laurence P Diggs, Sean P Martin, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 26, 2023
Combined hepatic resection and ablation for high burden of colorectal liver metastases demonstrates safety and durable survivalMichael M Wach, Laura A Washburn, Jurgis Alvikas, et al.
Annals of Surgical Oncology|January 25, 2024
Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal MetastasesMichael M Wach, Geoffrey Nunns, Ahmed Hamed, et al.
The American Surgeon|December 21, 2020
Patient Comorbidities Drive High Mortality Rates Associated with Major Liver Resections Irrespective of Hospital VolumeLaurence P Diggs, John G Aversa, Timothy L Wiemken, et al.
Neurosurgery|August 27, 2015
High-Risk Factors in Symptomatic Patients Undergoing Carotid Artery Stenting With Distal Protection: Buffalo Risk Assessment Scale (BRASS)Andrew A Fanous, Sabareesh K Natarajan, Patrick K Jowdy, et al.
Transplantation Proceedings|January 3, 2006
Addition of cladribine to induction/consolidation regimen does not impair peripheral blood stem cell mobilization and bone marrow harvest for autotransplantation in acute myeloid leukemia patientsJ Holowiecki, S Grosicki, M Sadus-Wojciechowska, et al.
Annals of Hematology|April 28, 2005
A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia GroupA Wrzesień-Kuś, T Robak, A Wierzbowska, et al.
Pageof 7